Hormone therapy and ovarian cancer - Authors' reply

Lancet. 2015 Sep 12;386(9998):1038-9. doi: 10.1016/S0140-6736(15)00140-3.

Authors

Valerie Beral¹, Carol Hermon², Richard Peto², Gillian Reeves²; Collaborative Group on Epidemiological Studies of Ovarian Cancer

Affiliations

¹ Nuffield Department of Population Health, Richard Doll Building, Headington, University of Oxford, Oxford OX3 7LF, UK. Electronic address: collaborations@ceu.ox.ac.uk.
² Nuffield Department of Population Health, Richard Doll Building, Headington, University of Oxford, Oxford OX3 7LF, UK.

PMID: 26382993
DOI: 10.1016/S0140-6736(15)00140-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Estrogen Replacement Therapy / adverse effects*
Female
Humans
Ovarian Neoplasms / chemically induced*
Ovarian Neoplasms / epidemiology*